does medicaid cover glp-1 for weight loss Medicare, will weight-loss drugs next year Connecticut is moving to eliminate

Regardless of cause, sustainability of outcomes remains unclear because adherence to treatment, as with many other drugs, may be an issue

Wang T, Hong JL, Gower EW, et al

They help you feel fuller for longer periods, making it easier to reduce caloric intake

If you experience any of the following, remain at your current dose for an additional 2 to 4 weeks before escalating: Nausea lasting more than 3 days after injection Vomiting more than once per week Inability to maintain adequate caloric intake (under 1,000 calories daily) Signs of dehydration despite increased fluid intake New onset of significant fatigue that interferes with daily function Slowing escalation is not failure

adults are overweight or obese, only four percent of these people are prescribed GLP-1 weight-loss medicines due to concerns about safety or effectiveness, lack of healthcare provider training in weight management, excessive costs due to insurance companies refusing coverage and a toxic stigma that portrays obesity as a lack of willpower